Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy EXACT Sciences Corporation stock

Learn how to easily invest in EXACT Sciences Corporation stock.

EXACT Sciences Corporation is a diagnostics & research business based in the US. EXACT Sciences Corporation shares (EXAS) are listed on the NASDAQ and all prices are listed in US Dollars. EXACT Sciences Corporation employs 6,420 staff and has a trailing 12-month revenue of around $1.9 billion.

How to buy shares in EXACT Sciences Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EXAS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

EXACT Sciences Corporation stock price (NASDAQ: EXAS)

Use our graph to track the performance of EXAS stocks over time.

EXACT Sciences Corporation shares at a glance

Information last updated 2022-10-02.
Latest market close$32.49
52-week range$31.62 - $104.50
50-day moving average $39.96
200-day moving average $57.09
Wall St. target price$70.06
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-4.33

Buy EXACT Sciences Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy EXACT Sciences Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

EXACT Sciences Corporation price performance over time

Historical closes compared with the close of $32.49 from 2022-09-30

1 week (2022-09-23) N/A
1 month (2022-09-01) -10.35%
3 months (2022-06-30) -17.52%
6 months (2022-04-04) -57.38%
1 year (2021-10-04) -65.14%
2 years (2020-10-02) -69.23%
3 years (2019-10-04) 93.28
5 years (2017-10-04) 47.99

EXACT Sciences Corporation financials

Revenue TTM $1.9 billion
Gross profit TTM $1.3 billion
Return on assets TTM -6.93%
Return on equity TTM -21.71%
Profit margin -37.9%
Book value $18.15
Market capitalisation $5.7 billion

TTM: trailing 12 months

EXACT Sciences Corporation share dividends

We're not expecting EXACT Sciences Corporation to pay a dividend over the next 12 months.

EXACT Sciences Corporation share price volatility

Over the last 12 months, EXACT Sciences Corporation's shares have ranged in value from as little as $31.62 up to $104.5. A popular way to gauge a stock's volatility is its "beta".

EXAS.US volatility(beta: 1.37)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while EXACT Sciences Corporation's is 1.3736. This would suggest that EXACT Sciences Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

EXACT Sciences Corporation overview

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; Oncomap ExTra, that provides a complete biological picture of certain refractory, rare, or aggressive cancers; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. .

Frequently asked questions

What percentage of EXACT Sciences Corporation is owned by insiders or institutions?
Currently 0.881% of EXACT Sciences Corporation shares are held by insiders and 86.609% by institutions.
How many people work for EXACT Sciences Corporation?
Latest data suggests 6,420 work at EXACT Sciences Corporation.
When does the fiscal year end for EXACT Sciences Corporation?
EXACT Sciences Corporation's fiscal year ends in December.
Where is EXACT Sciences Corporation based?
EXACT Sciences Corporation's address is: 5505 Endeavor Lane, Madison, WI, United States, 53719
What is EXACT Sciences Corporation's ISIN number?
EXACT Sciences Corporation's international securities identification number is: US30063P1057
What is EXACT Sciences Corporation's CUSIP number?
EXACT Sciences Corporation's Committee on Uniform Securities Identification Procedures number is: 30063P105

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site